Towards Healthcare Research & Consulting
U.S. Endobronchial Ultrasound Biopsy Market
Updated Date: 08 June 2026   |   Report Code: 6934

U.S. Endobronchial Ultrasound Biopsy Market Revolutionizing Lung Cancer Diagnosis Through AI-Powered Precision Bronchoscopy

According to Shivani Zoting, who specializes in U.S. endobronchial ultrasound biopsy markets, with years of experience in market research and industry analysis. My research indicates that the U.S. Endobronchial Ultrasound Biopsy Market will grow from USD 449.54 million in 2026 to USD 968.32 million by 2035 at a CAGR of 8.9%, driven by rising lung cancer screening and minimally invasive diagnostics. EBUS-TBNA, EBUS bronchoscopes, and hospitals lead the market, while innovation from Olympus, Medtronic, Fujifilm, Boston Scientific, and other key players continues to accelerate growth across the U.S.

Last Updated : 08 June 2026 Category: Medical Devices Insight Code: 6934 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Procedure Type
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Patient Type
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Biopsy Needle Size
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Endobronchial Ultrasound Biopsy Market Analysis, By Imaging Modality Integration
    • Market Size, Forecast & CAGR, By Procedure Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Procedure Type
      • By Product Type
      • By Application
      • By End User
      • By Patient Type
      • By Technology
      • By Biopsy Needle Size
      • By Imaging Modality Integration
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Company 1
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

FAQ's

Answer : The U.S. endobronchial ultrasound biopsy market in 2026 is valued at USD 449.54 million and is projected to climb to USD 968.32 million by 2035, with a CAGR of 8.9% over the forecast period.

Answer : The U.S. endobronchial ultrasound biopsy market is expected to show lucrative growth due to the growth in lung cancer rates.

Answer : American Lung Association, National Library of Medicine, American Cancer Society.

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar